Cite
Bolge SC, Eldridge HM, Lofland JH, et al. Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn's disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis. Patient Prefer Adherence. 2017;11:661-669doi: 10.2147/PPA.S121032.
Bolge, S. C., Eldridge, H. M., Lofland, J. H., Ravin, C., Hart, P. J., & Ingham, M. P. (2017). Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn's disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis. Patient preference and adherence, 11661-669. https://doi.org/10.2147/PPA.S121032
Bolge, Susan C, et al. "Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn's disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis." Patient preference and adherence vol. 11 (2017): 661-669. doi: https://doi.org/10.2147/PPA.S121032
Bolge SC, Eldridge HM, Lofland JH, Ravin C, Hart PJ, Ingham MP. Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn's disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis. Patient Prefer Adherence. 2017 Mar 28;11:661-669. doi: 10.2147/PPA.S121032. eCollection 2017. PMID: 28405158; PMCID: PMC5378465.
Copy
Download .nbib